Pharmacokinetics and Metabolism of SRX246: A Potent and Selective Vasopressin 1a Antagonist

Volume: 102, Issue: 6, Pages: 2033 - 2043
Published: Jun 1, 2013
Abstract
SRX246 is a potent, highly selective, orally bioavailable vasopressin 1a receptor antagonist that represents a novel mechanism of action for the treatment of mood disorders. The compound previously showed efficacy in animal models of mood disorders and excellent safety and tolerability in healthy volunteers in phase I clinical trials. In this study, SRX246 was further characterized in rats and dogs. In vitro determinations of permeability,...
Paper Details
Title
Pharmacokinetics and Metabolism of SRX246: A Potent and Selective Vasopressin 1a Antagonist
Published Date
Jun 1, 2013
Volume
102
Issue
6
Pages
2033 - 2043
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.